Delivery Order SPE2DB20D1047-SPE2DB25FF82A
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,040.74 for Carvedilol ER 10 mg capsules (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,687.29. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,255.74 for Carvedilol ER 20 mg capsules (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $2,427.22 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This competitive award, without set-aside designation, is classified as a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,578.12 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,168.50 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count) on April 9, 2025, with an ultimate completion date of April 10, 2025. This firm fixed-price delivery order was not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is performed at the awardee's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on January 10, 2025, with a ceiling value of $1,726.39 and an ultimate completion date of January 13, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and represents a direct procurement of pharmaceutical products to support federal medical supply needs. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $9,373.09. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for completion by August 21, 2025, with performance to take place at AmerisourceBergen's corporate headquarters in Conshohocken,...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF82ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) valued at $10,167.10 under a firm fixed-price contract type. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal healthcare procurement needs. This delivery order is issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999.99 million through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent competitive success in federal pharmaceutical procurement, as evidenced by this and numerous other delivery orders, demonstrates its capability to meet diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 9/8/25 |